Treating arthritis with 3-(N,N-dimethyl carbamoyl)pyrazolo[1,5-a]pyridine
US4604400A · kind A · utility
23Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 1984 |
| Grant date | Aug 5, 1986 |
| Priority date | — |
| Expiry date | Sep 13, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
3-(N,N-Dimethylcarbamoyl)pyrazolo[1,5-a]pyridine of the formula: ##STR1## which is a new compound, possesses pharmacological properties, in particular properties which are indicative of outstanding utility in the treatment of arthritic disorders such as rheumatoid arthritis. The compound can be prepared by reacting a pyrazolo[1,5-a]pyridine-3-carbonyl halide (e.g. chloride) with dimethylamine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.